Clearpoint Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Clearpoint Neuro
CLPT Stock  USD 10.40  0.26  2.44%   
Analyzing historical trends in various income statement and balance sheet accounts from Clearpoint Neuro's financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Clearpoint Neuro's valuation are summarized below:
Gross Profit
19.7 M
Profit Margin
(0.65)
Market Capitalization
294 M
Enterprise Value Revenue
8.85
Revenue
32.2 M
There are currently one hundred twenty fundamental signals for Clearpoint Neuro that can be evaluated and compared over time across rivals. All traders should validate Clearpoint Neuro's prevailing fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 436.5 M in 2025. Enterprise Value is likely to gain to about 419.1 M in 2025

Clearpoint Neuro Total Revenue

32.96 Million

Check Clearpoint Neuro financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Clearpoint Neuro's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 M, Interest Expense of 330 K or Selling General Administrative of 7.6 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 17.19. Clearpoint financial statements analysis is a perfect complement when working with Clearpoint Neuro Valuation or Volatility modules.
  
Build AI portfolio with Clearpoint Stock
Check out the analysis of Clearpoint Neuro Correlation against competitors.
For more information on how to buy Clearpoint Stock please use our How to Invest in Clearpoint Neuro guide.

Clearpoint Neuro Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding28.4 M27 M11.4 M
Slightly volatile
Total Assets24.6 M39.2 M21.3 M
Slightly volatile
Short and Long Term Debt Total3.4 M3.6 M8.2 M
Pretty Stable
Other Current Liabilities8.2 M7.8 M3.4 M
Slightly volatile
Total Current Liabilities10.9 M10.4 M7.1 M
Pretty Stable
Property Plant And Equipment Net5.3 M5.1 M2 M
Slightly volatile
Current Deferred Revenue2.2 M2.1 M1.1 M
Pretty Stable
Accounts Payable890 K1.3 M1.3 M
Slightly volatile
Cash14.6 M20.1 M12.6 M
Slightly volatile
Non Current Assets Total3.1 M5.8 M2.7 M
Slightly volatile
Non Currrent Assets Other238.4 K251 K639.7 K
Pretty Stable
Cash And Short Term Investments15.4 M20.1 M13.2 M
Slightly volatile
Net Receivables4.9 M4.7 M1.8 M
Slightly volatile
Common Stock Total Equity263.6 K221.4 K303.1 K
Slightly volatile
Liabilities And Stockholders Equity24.6 M39.2 M21.3 M
Slightly volatile
Non Current Liabilities Total3.3 M3.4 M8.2 M
Very volatile
Inventory3.8 M6.9 M3.4 M
Slightly volatile
Other Current Assets1.8 M1.7 M575.3 K
Slightly volatile
Other Stockholder Equity144.7 M216.5 M129.7 M
Slightly volatile
Total Liabilities16.1 M13.8 M15.3 M
Very volatile
Property Plant And Equipment Gross6.8 M6.4 M2.2 M
Slightly volatile
Total Current Assets21.6 M33.4 M18.6 M
Slightly volatile
Short Term Debt529.1 K557 K1.8 M
Slightly volatile
Common Stock255.9 K276 K306.1 K
Pretty Stable
Intangible Assets574.5 K484 K601.8 K
Pretty Stable
Other Assets1.3 M668.1 K1 M
Very volatile
Long Term Debt8.3 M11.4 M6.6 M
Slightly volatile
Long Term Debt Total7.9 M11.4 M6.6 M
Slightly volatile
Capital Surpluse137.6 M215.1 M122.4 M
Slightly volatile
Property Plant Equipment1.3 M1.4 M969.5 K
Slightly volatile
Other Liabilities505.7 K351 K597.3 K
Slightly volatile
Net Invested Capital28.6 M25.4 M19.5 M
Slightly volatile
Short and Long Term Debt1.6 M1.8 M2 M
Slightly volatile
Net Working Capital26.8 M23 M17.5 M
Slightly volatile
Capital Stock226.1 K276 K159.1 K
Slightly volatile
Capital Lease Obligations2.8 M3.6 M1.4 M
Slightly volatile
Deferred Long Term Liabilities318.6 K448.5 K261 K
Slightly volatile
Non Current Liabilities Other1.6 M1.4 M2.2 M
Slightly volatile

Clearpoint Neuro Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization2 M1.9 M628.9 K
Slightly volatile
Interest Expense330 K347.4 K1.1 M
Slightly volatile
Selling General Administrative7.6 M12 M6.9 M
Slightly volatile
Total Revenue33 M31.4 M12.1 M
Slightly volatile
Gross Profit20.1 M19.1 M7.7 M
Slightly volatile
Other Operating Expenses53.7 M51.1 M22.3 M
Slightly volatile
Research Development13 M12.4 M5.8 M
Slightly volatile
Cost Of Revenue12.9 M12.3 M4.3 M
Slightly volatile
Total Operating Expenses40.8 M38.9 M18 M
Slightly volatile
Interest Income672.6 K872 K473.8 K
Slightly volatile
Selling And Marketing Expenses7.9 M14.5 M6 M
Slightly volatile
Reconciled Depreciation2 M1.9 M491.5 K
Slightly volatile

Clearpoint Neuro Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation7.3 M6.9 M2.4 M
Slightly volatile
Begin Period Cash Flow12.5 M23.1 M11.4 M
Slightly volatile
Depreciation2 M1.9 M629.1 K
Slightly volatile
Capital Expenditures292.5 K275 K267.5 K
Slightly volatile
End Period Cash Flow13.8 M20.1 M12.6 M
Slightly volatile
Change To Netincome4.8 M4.6 M1.9 M
Slightly volatile
Dividends Paid254.4 K183.6 K376.9 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio7.3613.24269.0825
Pretty Stable
Days Sales Outstanding43.0354.802352.1547
Very volatile
Average Payables688.5 K724.7 K1.2 M
Slightly volatile
Stock Based Compensation To Revenue0.230.220.2141
Slightly volatile
Capex To Depreciation0.140.14450.4502
Slightly volatile
EV To Sales10.4712.71589.2985
Very volatile
Inventory Turnover1.881.78761.1243
Slightly volatile
Days Of Inventory On Hand394204372
Slightly volatile
Payables Turnover6.069.15527.0126
Slightly volatile
Sales General And Administrative To Revenue0.550.38220.5913
Slightly volatile
Average Inventory1.2 M1.6 M1.6 M
Slightly volatile
Research And Ddevelopement To Revenue0.690.39480.6298
Slightly volatile
Capex To Revenue0.00830.00880.0211
Very volatile
Cash Per Share0.710.74381.5526
Pretty Stable
Days Payables Outstanding37.8739.8679443
Slightly volatile
Income Quality0.450.47320.8734
Slightly volatile
Intangibles To Total Assets0.01170.01240.0488
Slightly volatile
Current Ratio2.983.22253.4586
Slightly volatile
Receivables Turnover8.046.66037.4922
Pretty Stable
Capex Per Share0.00970.01020.0468
Slightly volatile
Average Receivables684.5 K982.5 K911.9 K
Slightly volatile
Revenue Per Share1.11.16142.444
Slightly volatile
Interest Debt Per Share0.130.1325.1723
Slightly volatile
Debt To Assets0.08650.0910.7426
Slightly volatile
Operating Cycle454259425
Slightly volatile
Days Of Payables Outstanding37.8739.8679443
Slightly volatile
Ebt Per Ebit1.220.95791.1179
Pretty Stable
Quick Ratio2.462.55962.849
Slightly volatile
Net Income Per E B T1.261.161.1612
Pretty Stable
Cash Ratio2.071.94192.3939
Slightly volatile
Days Of Inventory Outstanding394204372
Slightly volatile
Days Of Sales Outstanding43.0354.802352.1547
Very volatile
Free Cash Flow Operating Cash Flow Ratio0.821.03071.0145
Pretty Stable
Fixed Asset Turnover7.786.16589.1837
Very volatile
Debt Ratio0.08650.0910.7426
Slightly volatile
Price Sales Ratio7.3613.24269.0825
Pretty Stable
Asset Turnover0.70.8010.6845
Slightly volatile
Gross Profit Margin0.740.60920.6774
Slightly volatile

Clearpoint Neuro Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap436.5 M415.7 M130.9 M
Slightly volatile
Enterprise Value419.1 M399.1 M124.2 M
Slightly volatile

Clearpoint Fundamental Market Drivers

Cash And Short Term Investments20.1 M

Clearpoint Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Clearpoint Neuro Financial Statements

Clearpoint Neuro shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Clearpoint Neuro investors may analyze each financial statement separately, they are all interrelated. The changes in Clearpoint Neuro's assets and liabilities, for example, are also reflected in the revenues and expenses on on Clearpoint Neuro's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue2.1 M2.2 M
Total Revenue31.4 M33 M
Cost Of Revenue12.3 M12.9 M
Stock Based Compensation To Revenue 0.22  0.23 
Sales General And Administrative To Revenue 0.38  0.55 
Research And Ddevelopement To Revenue 0.39  0.69 
Capex To Revenue 0.01  0.01 
Revenue Per Share 1.16  1.10 
Ebit Per Revenue(0.63)(0.66)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Clearpoint Stock Analysis

When running Clearpoint Neuro's price analysis, check to measure Clearpoint Neuro's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearpoint Neuro is operating at the current time. Most of Clearpoint Neuro's value examination focuses on studying past and present price action to predict the probability of Clearpoint Neuro's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearpoint Neuro's price. Additionally, you may evaluate how the addition of Clearpoint Neuro to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY